September 12, 2024CorporateMicroVention Rebrands to Terumo Neuro - Reflects Expanded Focus and Strategic Growth
Refining Searches 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Corporate Financial March 25, 2014 Corporate Terumo BCT Becomes Therakos Inc. Distributor in Latin America Multi-year agreement enables Terumo BCT to provide Therakos products in several Latin American countries March 14, 2014 Corporate Terumo Announces Exclusive Acquisition Right Agreement with French Bioresorbable Scaffold Company, "ART" February 12, 2014 Corporate Terumo Wins Pharmapack 2014 Award For Nanopass® 34 Pen-Needle In The Category "Quality Of Life" February 03, 2014 Corporate Terumo Receives CE Mark for Its New Drug-eluting Stent, Ultimaster™ January 28, 2014 Corporate Nonin Medical Announces U.K. and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart™ Universal Oximetry System January 28, 2014 Corporate U.S. Food and Drug Administration Clears Granulocyte Collection Procedure on the Spectra Optia Apheresis System Granulocyte, or polymorphonuclear [PMN] cell, collections on the next-generation therapeutic apheresis platform to optimize cellular collections and supplement current protocol offering Pagination Previous page ‹ Page1 … Page8 Page9 Current page10 Next page ›
March 25, 2014 Corporate Terumo BCT Becomes Therakos Inc. Distributor in Latin America Multi-year agreement enables Terumo BCT to provide Therakos products in several Latin American countries
March 14, 2014 Corporate Terumo Announces Exclusive Acquisition Right Agreement with French Bioresorbable Scaffold Company, "ART"
February 12, 2014 Corporate Terumo Wins Pharmapack 2014 Award For Nanopass® 34 Pen-Needle In The Category "Quality Of Life"
January 28, 2014 Corporate Nonin Medical Announces U.K. and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart™ Universal Oximetry System
January 28, 2014 Corporate U.S. Food and Drug Administration Clears Granulocyte Collection Procedure on the Spectra Optia Apheresis System Granulocyte, or polymorphonuclear [PMN] cell, collections on the next-generation therapeutic apheresis platform to optimize cellular collections and supplement current protocol offering